Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive protein

被引:18
作者
Zeltser, D [1 ]
Rogowski, O [1 ]
Mardi, T [1 ]
Justo, D [1 ]
Tolshinsky, T [1 ]
Goldin, Y [1 ]
Burke, M [1 ]
Deutsch, V [1 ]
Berliner, S [1 ]
Shapira, I [1 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Internal Med D, IL-69978 Tel Aviv, Israel
关键词
C-reactive protein; atherothrombosis; low-grade inflammation;
D O I
10.1016/j.atherosclerosis.2004.04.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To clarify whether individuals with low concentrations of highly sensitive C-reactive protein (hs-CRP) are free of atherothrombotic risk factors or low-grade inflammation. Methods and results: This cross-sectional study included 1266 individuals with risk factors (diabetes, hypertension, hyperlipidemia, smoking, obesity). Eighty percent of women and the same percentage of men with a low concentration (0.8 +/- 0.4 mg/l) of hs-CRP had at least one atherothrombotic risk factor. About one-fourth of the females and a one-third of the males with a low concentration of hs-CRP had at least one laboratory marker of chronic inflammation (erythrocyte sedimentation rate (ESR), white blood cell count (WBCC) or fibrinogen concentration) in the upper 75th percentile. Conclusion: Individuals presenting with low concentrations of hs-CRP are not necessarily free of atherothrombotic risk factors. One-fourth of the females and a third of the males in this group presented laboratory evidence of a low-grade inflammation as detected by increased erythrocyte sedimentation rate, white blood cell count or fibrinogen concentration. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:297 / 301
页数:5
相关论文
共 14 条
[1]   Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study [J].
Brown, DA ;
Breit, SN ;
Buring, J ;
Fairlie, WD ;
Bauskin, AR ;
Liu, T ;
Ridker, PM .
LANCET, 2002, 359 (9324) :2159-2163
[2]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[3]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[4]   Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men [J].
Engström, G ;
Lind, P ;
Hedblad, B ;
Stavenow, L ;
Janzon, L ;
Lindgärde, F .
CIRCULATION, 2002, 105 (22) :2632-2637
[5]   Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality [J].
Erikssen, G ;
Liestol, K ;
Bjornholt, JV ;
Stormorken, H ;
Thaulow, E ;
Erikssen, J .
EUROPEAN HEART JOURNAL, 2000, 21 (19) :1614-1620
[6]  
*INT COMM STAND HE, 1965, IMMUNOCHEMISTRY, V2, P235
[7]   Statins as potent antiinflammatory drugs [J].
Lefer, DJ .
CIRCULATION, 2002, 106 (16) :2041-2042
[8]   Inflammation and atherosclerosis [J].
Libby, P ;
Ridker, PM ;
Maseri, A .
CIRCULATION, 2002, 105 (09) :1135-1143
[9]   High-sensitivity C-reactive protein - Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease [J].
Ridker, PM .
CIRCULATION, 2001, 103 (13) :1813-1818
[10]   On evolutionary biology, inflammation, infection, and the causes of atherosclerosis [J].
Ridker, PM .
CIRCULATION, 2002, 105 (01) :2-4